HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition Article Swipe
Nicolas Jouand
,
Céline Bressollette‐Bodin
,
Nathalie Gérard
,
Magali Giral
,
Pierrick Guérif
,
Audrey Rodallec
,
Romain Oger
,
Tiphaine Parrot
,
Mathilde Allard
,
Anne Cesbron‐Gautier
,
Nadine Gervois
,
Béatrice Charreau
·
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1371/journal.ppat.1007041
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1371/journal.ppat.1007041
Immune response against human cytomegalovirus (HCMV) includes a set of persistent cytotoxic NK and CD8 T cells devoted to eliminate infected cells and to prevent reactivation. CD8 T cells against HCMV antigens (pp65, IE1) presented by HLA class-I molecules are well characterized and they associate with efficient virus control. HLA-E-restricted CD8 T cells targeting HCMV UL40 signal peptides (HLA-EUL40) have recently emerged as a non-conventional T-cell response also observed in some hosts. The occurrence, specificity and features of HLA-EUL40 CD8 T-cell responses remain mostly unknown. Here, we detected and quantified these responses in blood samples from healthy blood donors (n = 25) and kidney transplant recipients (n = 121) and we investigated the biological determinants involved in their occurrence. Longitudinal and phenotype ex vivo analyses were performed in comparison to HLA-A*02/pp65-specific CD8 T cells. Using a set of 11 HLA-E/UL40 peptide tetramers we demonstrated the presence of HLA-EUL40 CD8 αβT cells in up to 32% of seropositive HCMV+ hosts that may represent up to 38% of total circulating CD8 T-cells at a time point suggesting a strong expansion post-infection. Host's HLA-A*02 allele, HLA-E *01:01/*01:03 genotype and sequence of the UL40 peptide from the infecting strain are major factors affecting the incidence of HLA-EUL40 CD8 T cells. These cells are effector memory CD8 (CD45RAhighROlow, CCR7-, CD27-, CD28-) characterized by a low level of PD-1 expression. HLA-EUL40 responses appear early post-infection and display a broad, unbiased, Vβ repertoire. Although induced in HCMV strain-dependent, UL4015-23-specific manner, HLA-EUL40 CD8 T cells are reactive toward a broader set of nonapeptides varying in 1-3 residues including most HLA-I signal peptides. Thus, HCMV induces strong and life-long lasting HLA-EUL40 CD8 T cells with potential allogeneic or/and autologous reactivity that take place selectively in at least a third of infections according to virus strain and host HLA concordance.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1371/journal.ppat.1007041
- https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1007041&type=printable
- OA Status
- gold
- Cited By
- 37
- References
- 61
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2802657422
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2802657422Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1371/journal.ppat.1007041Digital Object Identifier
- Title
-
HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognitionWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2018Year of publication
- Publication date
-
2018-04-30Full publication date if available
- Authors
-
Nicolas Jouand, Céline Bressollette‐Bodin, Nathalie Gérard, Magali Giral, Pierrick Guérif, Audrey Rodallec, Romain Oger, Tiphaine Parrot, Mathilde Allard, Anne Cesbron‐Gautier, Nadine Gervois, Béatrice CharreauList of authors in order
- Landing page
-
https://doi.org/10.1371/journal.ppat.1007041Publisher landing page
- PDF URL
-
https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1007041&type=printableDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1007041&type=printableDirect OA link when available
- Concepts
-
Cytotoxic T cell, CD8, Biology, Human leukocyte antigen, Immunology, T cell, CD28, Human cytomegalovirus, Antigen, Immune system, Virology, Virus, In vitro, GeneticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
37Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2024: 4, 2023: 6, 2022: 8, 2021: 6Per-year citation counts (last 5 years)
- References (count)
-
61Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2802657422 |
|---|---|
| doi | https://doi.org/10.1371/journal.ppat.1007041 |
| ids.doi | https://doi.org/10.1371/journal.ppat.1007041 |
| ids.mag | 2802657422 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/29709038 |
| ids.openalex | https://openalex.org/W2802657422 |
| fwci | 3.6658499 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000328 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Adult |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D000368 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Aged |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D017951 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Antigen Presentation |
| mesh[3].qualifier_ui | Q000276 |
| mesh[3].descriptor_ui | D018414 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | immunology |
| mesh[3].descriptor_name | CD8-Positive T-Lymphocytes |
| mesh[4].qualifier_ui | Q000378 |
| mesh[4].descriptor_ui | D018414 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | metabolism |
| mesh[4].descriptor_name | CD8-Positive T-Lymphocytes |
| mesh[5].qualifier_ui | Q000821 |
| mesh[5].descriptor_ui | D018414 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | virology |
| mesh[5].descriptor_name | CD8-Positive T-Lymphocytes |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D016022 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Case-Control Studies |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D002478 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Cells, Cultured |
| mesh[8].qualifier_ui | Q000187 |
| mesh[8].descriptor_ui | D003587 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | drug effects |
| mesh[8].descriptor_name | Cytomegalovirus |
| mesh[9].qualifier_ui | Q000276 |
| mesh[9].descriptor_ui | D003587 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | immunology |
| mesh[9].descriptor_name | Cytomegalovirus |
| mesh[10].qualifier_ui | Q000188 |
| mesh[10].descriptor_ui | D003586 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | drug therapy |
| mesh[10].descriptor_name | Cytomegalovirus Infections |
| mesh[11].qualifier_ui | Q000276 |
| mesh[11].descriptor_ui | D003586 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | immunology |
| mesh[11].descriptor_name | Cytomegalovirus Infections |
| mesh[12].qualifier_ui | Q000378 |
| mesh[12].descriptor_ui | D003586 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | metabolism |
| mesh[12].descriptor_name | Cytomegalovirus Infections |
| mesh[13].qualifier_ui | Q000821 |
| mesh[13].descriptor_ui | D003586 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | virology |
| mesh[13].descriptor_name | Cytomegalovirus Infections |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D005260 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Female |
| mesh[15].qualifier_ui | Q000276 |
| mesh[15].descriptor_ui | D015395 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | immunology |
| mesh[15].descriptor_name | Histocompatibility Antigens Class I |
| mesh[16].qualifier_ui | Q000378 |
| mesh[16].descriptor_ui | D015395 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | metabolism |
| mesh[16].descriptor_name | Histocompatibility Antigens Class I |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D006801 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Humans |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D016030 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Kidney Transplantation |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D008297 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Male |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D008875 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Middle Aged |
| mesh[21].qualifier_ui | Q000494 |
| mesh[21].descriptor_ui | D010446 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | pharmacology |
| mesh[21].descriptor_name | Peptide Fragments |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D012189 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Retrospective Studies |
| mesh[23].qualifier_ui | Q000187 |
| mesh[23].descriptor_ui | D013602 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | drug effects |
| mesh[23].descriptor_name | T-Lymphocytes, Cytotoxic |
| mesh[24].qualifier_ui | Q000276 |
| mesh[24].descriptor_ui | D013602 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | immunology |
| mesh[24].descriptor_name | T-Lymphocytes, Cytotoxic |
| mesh[25].qualifier_ui | Q000378 |
| mesh[25].descriptor_ui | D013602 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | metabolism |
| mesh[25].descriptor_name | T-Lymphocytes, Cytotoxic |
| mesh[26].qualifier_ui | Q000821 |
| mesh[26].descriptor_ui | D013602 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | virology |
| mesh[26].descriptor_name | T-Lymphocytes, Cytotoxic |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D014182 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Transplantation, Autologous |
| mesh[28].qualifier_ui | Q000378 |
| mesh[28].descriptor_ui | D014764 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | metabolism |
| mesh[28].descriptor_name | Viral Proteins |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D000097625 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | HLA-E Antigens |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D000328 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Adult |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D000368 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Aged |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D017951 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Antigen Presentation |
| mesh[33].qualifier_ui | Q000276 |
| mesh[33].descriptor_ui | D018414 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | immunology |
| mesh[33].descriptor_name | CD8-Positive T-Lymphocytes |
| mesh[34].qualifier_ui | Q000378 |
| mesh[34].descriptor_ui | D018414 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | metabolism |
| mesh[34].descriptor_name | CD8-Positive T-Lymphocytes |
| mesh[35].qualifier_ui | Q000821 |
| mesh[35].descriptor_ui | D018414 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | virology |
| mesh[35].descriptor_name | CD8-Positive T-Lymphocytes |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D016022 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Case-Control Studies |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D002478 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Cells, Cultured |
| mesh[38].qualifier_ui | Q000187 |
| mesh[38].descriptor_ui | D003587 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | drug effects |
| mesh[38].descriptor_name | Cytomegalovirus |
| mesh[39].qualifier_ui | Q000276 |
| mesh[39].descriptor_ui | D003587 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | immunology |
| mesh[39].descriptor_name | Cytomegalovirus |
| mesh[40].qualifier_ui | Q000188 |
| mesh[40].descriptor_ui | D003586 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | drug therapy |
| mesh[40].descriptor_name | Cytomegalovirus Infections |
| mesh[41].qualifier_ui | Q000276 |
| mesh[41].descriptor_ui | D003586 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | immunology |
| mesh[41].descriptor_name | Cytomegalovirus Infections |
| mesh[42].qualifier_ui | Q000378 |
| mesh[42].descriptor_ui | D003586 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | metabolism |
| mesh[42].descriptor_name | Cytomegalovirus Infections |
| mesh[43].qualifier_ui | Q000821 |
| mesh[43].descriptor_ui | D003586 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | virology |
| mesh[43].descriptor_name | Cytomegalovirus Infections |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D005260 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Female |
| mesh[45].qualifier_ui | Q000276 |
| mesh[45].descriptor_ui | D015395 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | immunology |
| mesh[45].descriptor_name | Histocompatibility Antigens Class I |
| mesh[46].qualifier_ui | Q000378 |
| mesh[46].descriptor_ui | D015395 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | metabolism |
| mesh[46].descriptor_name | Histocompatibility Antigens Class I |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D006801 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Humans |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D016030 |
| mesh[48].is_major_topic | True |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Kidney Transplantation |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D008297 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Male |
| type | article |
| title | HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition |
| biblio.issue | 4 |
| biblio.volume | 14 |
| biblio.last_page | e1007041 |
| biblio.first_page | e1007041 |
| grants[0].funder | https://openalex.org/F4320322727 |
| grants[0].award_id | allocation doctorale |
| grants[0].funder_display_name | Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche |
| grants[1].funder | https://openalex.org/F4320323585 |
| grants[1].award_id | Appel d'Offre Recherche et Greffe 2013 |
| grants[1].funder_display_name | Agence de la Biomédecine |
| topics[0].id | https://openalex.org/T10981 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2713 |
| topics[0].subfield.display_name | Epidemiology |
| topics[0].display_name | Cytomegalovirus and herpesvirus research |
| topics[1].id | https://openalex.org/T11020 |
| topics[1].field.id | https://openalex.org/fields/24 |
| topics[1].field.display_name | Immunology and Microbiology |
| topics[1].score | 0.9998999834060669 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2403 |
| topics[1].subfield.display_name | Immunology |
| topics[1].display_name | Immune Cell Function and Interaction |
| topics[2].id | https://openalex.org/T10031 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9994000196456909 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | T-cell and B-cell Immunology |
| funders[0].id | https://openalex.org/F4320322727 |
| funders[0].ror | https://ror.org/03sjk9a61 |
| funders[0].display_name | Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche |
| funders[1].id | https://openalex.org/F4320323585 |
| funders[1].ror | https://ror.org/03tajza86 |
| funders[1].display_name | Agence de la Biomédecine |
| is_xpac | False |
| apc_list.value | 2655 |
| apc_list.currency | USD |
| apc_list.value_usd | 2655 |
| apc_paid.value | 1911 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 2061 |
| concepts[0].id | https://openalex.org/C154317977 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7802881598472595 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q376266 |
| concepts[0].display_name | Cytotoxic T cell |
| concepts[1].id | https://openalex.org/C167672396 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7002096176147461 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q417800 |
| concepts[1].display_name | CD8 |
| concepts[2].id | https://openalex.org/C86803240 |
| concepts[2].level | 0 |
| concepts[2].score | 0.6073054671287537 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[2].display_name | Biology |
| concepts[3].id | https://openalex.org/C188280979 |
| concepts[3].level | 3 |
| concepts[3].score | 0.5942879915237427 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q911125 |
| concepts[3].display_name | Human leukocyte antigen |
| concepts[4].id | https://openalex.org/C203014093 |
| concepts[4].level | 1 |
| concepts[4].score | 0.548845648765564 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[4].display_name | Immunology |
| concepts[5].id | https://openalex.org/C2776090121 |
| concepts[5].level | 3 |
| concepts[5].score | 0.4947466552257538 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q193529 |
| concepts[5].display_name | T cell |
| concepts[6].id | https://openalex.org/C148125776 |
| concepts[6].level | 4 |
| concepts[6].score | 0.43531373143196106 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1622348 |
| concepts[6].display_name | CD28 |
| concepts[7].id | https://openalex.org/C2779820661 |
| concepts[7].level | 3 |
| concepts[7].score | 0.4311392605304718 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q6929 |
| concepts[7].display_name | Human cytomegalovirus |
| concepts[8].id | https://openalex.org/C147483822 |
| concepts[8].level | 2 |
| concepts[8].score | 0.42433977127075195 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q103537 |
| concepts[8].display_name | Antigen |
| concepts[9].id | https://openalex.org/C8891405 |
| concepts[9].level | 2 |
| concepts[9].score | 0.40672022104263306 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[9].display_name | Immune system |
| concepts[10].id | https://openalex.org/C159047783 |
| concepts[10].level | 1 |
| concepts[10].score | 0.3500049114227295 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[10].display_name | Virology |
| concepts[11].id | https://openalex.org/C2522874641 |
| concepts[11].level | 2 |
| concepts[11].score | 0.20554354786872864 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q808 |
| concepts[11].display_name | Virus |
| concepts[12].id | https://openalex.org/C202751555 |
| concepts[12].level | 2 |
| concepts[12].score | 0.11900857090950012 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[12].display_name | In vitro |
| concepts[13].id | https://openalex.org/C54355233 |
| concepts[13].level | 1 |
| concepts[13].score | 0.10064604878425598 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[13].display_name | Genetics |
| keywords[0].id | https://openalex.org/keywords/cytotoxic-t-cell |
| keywords[0].score | 0.7802881598472595 |
| keywords[0].display_name | Cytotoxic T cell |
| keywords[1].id | https://openalex.org/keywords/cd8 |
| keywords[1].score | 0.7002096176147461 |
| keywords[1].display_name | CD8 |
| keywords[2].id | https://openalex.org/keywords/biology |
| keywords[2].score | 0.6073054671287537 |
| keywords[2].display_name | Biology |
| keywords[3].id | https://openalex.org/keywords/human-leukocyte-antigen |
| keywords[3].score | 0.5942879915237427 |
| keywords[3].display_name | Human leukocyte antigen |
| keywords[4].id | https://openalex.org/keywords/immunology |
| keywords[4].score | 0.548845648765564 |
| keywords[4].display_name | Immunology |
| keywords[5].id | https://openalex.org/keywords/t-cell |
| keywords[5].score | 0.4947466552257538 |
| keywords[5].display_name | T cell |
| keywords[6].id | https://openalex.org/keywords/cd28 |
| keywords[6].score | 0.43531373143196106 |
| keywords[6].display_name | CD28 |
| keywords[7].id | https://openalex.org/keywords/human-cytomegalovirus |
| keywords[7].score | 0.4311392605304718 |
| keywords[7].display_name | Human cytomegalovirus |
| keywords[8].id | https://openalex.org/keywords/antigen |
| keywords[8].score | 0.42433977127075195 |
| keywords[8].display_name | Antigen |
| keywords[9].id | https://openalex.org/keywords/immune-system |
| keywords[9].score | 0.40672022104263306 |
| keywords[9].display_name | Immune system |
| keywords[10].id | https://openalex.org/keywords/virology |
| keywords[10].score | 0.3500049114227295 |
| keywords[10].display_name | Virology |
| keywords[11].id | https://openalex.org/keywords/virus |
| keywords[11].score | 0.20554354786872864 |
| keywords[11].display_name | Virus |
| keywords[12].id | https://openalex.org/keywords/in-vitro |
| keywords[12].score | 0.11900857090950012 |
| keywords[12].display_name | In vitro |
| keywords[13].id | https://openalex.org/keywords/genetics |
| keywords[13].score | 0.10064604878425598 |
| keywords[13].display_name | Genetics |
| language | en |
| locations[0].id | doi:10.1371/journal.ppat.1007041 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2004986 |
| locations[0].source.issn | 1553-7366, 1553-7374 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1553-7366 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | PLoS Pathogens |
| locations[0].source.host_organization | https://openalex.org/P4310315706 |
| locations[0].source.host_organization_name | Public Library of Science |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315706 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1007041&type=printable |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | PLOS Pathogens |
| locations[0].landing_page_url | https://doi.org/10.1371/journal.ppat.1007041 |
| locations[1].id | pmid:29709038 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | PLoS pathogens |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/29709038 |
| locations[2].id | pmh:oai:europepmc.org:4918988 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | cc-by |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | http://europepmc.org/pmc/articles/PMC5945056 |
| locations[3].id | pmh:oai:doaj.org/article:798f8015a1f94ef1b8809ee1dc01b133 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | cc-by-sa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | PLoS Pathogens, Vol 14, Iss 4, p e1007041 (2018) |
| locations[3].landing_page_url | https://doaj.org/article/798f8015a1f94ef1b8809ee1dc01b133 |
| locations[4].id | pmh:oai:HAL:inserm-01812003v1 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S4306402512 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | HAL (Le Centre pour la Communication Scientifique Directe) |
| locations[4].source.host_organization | https://openalex.org/I1294671590 |
| locations[4].source.host_organization_name | Centre National de la Recherche Scientifique |
| locations[4].source.host_organization_lineage | https://openalex.org/I1294671590 |
| locations[4].license | other-oa |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | Journal articles |
| locations[4].license_id | https://openalex.org/licenses/other-oa |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | PLoS Pathogens, 2018, 14 (4), pp.e1007041. ⟨10.1371/journal.ppat.1007041⟩ |
| locations[4].landing_page_url | https://inserm.hal.science/inserm-01812003 |
| locations[5].id | pmh:oai:figshare.com:article/6202946 |
| locations[5].is_oa | True |
| locations[5].source.id | https://openalex.org/S4306400572 |
| locations[5].source.issn | |
| locations[5].source.type | repository |
| locations[5].source.is_oa | False |
| locations[5].source.issn_l | |
| locations[5].source.is_core | False |
| locations[5].source.is_in_doaj | False |
| locations[5].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[5].source.host_organization | https://openalex.org/I196829312 |
| locations[5].source.host_organization_name | La Trobe University |
| locations[5].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[5].license | cc-by |
| locations[5].pdf_url | |
| locations[5].version | submittedVersion |
| locations[5].raw_type | Dataset |
| locations[5].license_id | https://openalex.org/licenses/cc-by |
| locations[5].is_accepted | False |
| locations[5].is_published | False |
| locations[5].raw_source_name | |
| locations[5].landing_page_url | https://figshare.com/articles/dataset/HCMV_triggers_frequent_and_persistent_UL40-specific_unconventional_HLA-E-restricted_CD8_T-cell_responses_with_potential_autologous_and_allogeneic_peptide_recognition/6202946 |
| locations[6].id | pmh:oai:pubmedcentral.nih.gov:5945056 |
| locations[6].is_oa | True |
| locations[6].source.id | https://openalex.org/S2764455111 |
| locations[6].source.issn | |
| locations[6].source.type | repository |
| locations[6].source.is_oa | False |
| locations[6].source.issn_l | |
| locations[6].source.is_core | False |
| locations[6].source.is_in_doaj | False |
| locations[6].source.display_name | PubMed Central |
| locations[6].source.host_organization | https://openalex.org/I1299303238 |
| locations[6].source.host_organization_name | National Institutes of Health |
| locations[6].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[6].license | cc-by |
| locations[6].pdf_url | |
| locations[6].version | submittedVersion |
| locations[6].raw_type | Text |
| locations[6].license_id | https://openalex.org/licenses/cc-by |
| locations[6].is_accepted | False |
| locations[6].is_published | False |
| locations[6].raw_source_name | PLoS Pathog |
| locations[6].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/5945056 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5082674992 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-4967-5909 |
| authorships[0].author.display_name | Nicolas Jouand |
| authorships[0].countries | FR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I49451733, https://openalex.org/I97188460 |
| authorships[0].affiliations[0].raw_affiliation_string | CRCINA, UMR1232, INSERM, Université d'Angers, Université de Nantes, Nantes, France |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I154526488, https://openalex.org/I97188460 |
| authorships[0].affiliations[1].raw_affiliation_string | Centre de Recherche en Transplantation et Immunologie (CRTI), UMR1064, INSERM, Université de Nantes, Nantes, France |
| authorships[0].affiliations[2].raw_affiliation_string | LabEx Immunology-Graft-Oncology (IGO), Nantes, France |
| authorships[0].affiliations[3].institution_ids | https://openalex.org/I4210112643 |
| authorships[0].affiliations[3].raw_affiliation_string | Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France |
| authorships[0].institutions[0].id | https://openalex.org/I154526488 |
| authorships[0].institutions[0].ror | https://ror.org/02vjkv261 |
| authorships[0].institutions[0].type | government |
| authorships[0].institutions[0].lineage | https://openalex.org/I154526488 |
| authorships[0].institutions[0].country_code | FR |
| authorships[0].institutions[0].display_name | Inserm |
| authorships[0].institutions[1].id | https://openalex.org/I4210112643 |
| authorships[0].institutions[1].ror | https://ror.org/02dm0bq25 |
| authorships[0].institutions[1].type | facility |
| authorships[0].institutions[1].lineage | https://openalex.org/I154526488, https://openalex.org/I4210105774, https://openalex.org/I4210112643 |
| authorships[0].institutions[1].country_code | FR |
| authorships[0].institutions[1].display_name | Institut de Transplantation Urologie en Nephrologie |
| authorships[0].institutions[2].id | https://openalex.org/I97188460 |
| authorships[0].institutions[2].ror | https://ror.org/03gnr7b55 |
| authorships[0].institutions[2].type | education |
| authorships[0].institutions[2].lineage | https://openalex.org/I97188460 |
| authorships[0].institutions[2].country_code | FR |
| authorships[0].institutions[2].display_name | Nantes Université |
| authorships[0].institutions[3].id | https://openalex.org/I49451733 |
| authorships[0].institutions[3].ror | https://ror.org/04yrqp957 |
| authorships[0].institutions[3].type | education |
| authorships[0].institutions[3].lineage | https://openalex.org/I49451733 |
| authorships[0].institutions[3].country_code | FR |
| authorships[0].institutions[3].display_name | Université d'Angers |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Nicolas Jouand |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | CRCINA, UMR1232, INSERM, Université d'Angers, Université de Nantes, Nantes, France, Centre de Recherche en Transplantation et Immunologie (CRTI), UMR1064, INSERM, Université de Nantes, Nantes, France, Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France, LabEx Immunology-Graft-Oncology (IGO), Nantes, France |
| authorships[1].author.id | https://openalex.org/A5046171847 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-5175-0790 |
| authorships[1].author.display_name | Céline Bressollette‐Bodin |
| authorships[1].countries | FR |
| authorships[1].affiliations[0].raw_affiliation_string | Laboratoire de Virologie, CHU Nantes, Nantes, France |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I154526488, https://openalex.org/I97188460 |
| authorships[1].affiliations[1].raw_affiliation_string | Centre de Recherche en Transplantation et Immunologie (CRTI), UMR1064, INSERM, Université de Nantes, Nantes, France |
| authorships[1].institutions[0].id | https://openalex.org/I154526488 |
| authorships[1].institutions[0].ror | https://ror.org/02vjkv261 |
| authorships[1].institutions[0].type | government |
| authorships[1].institutions[0].lineage | https://openalex.org/I154526488 |
| authorships[1].institutions[0].country_code | FR |
| authorships[1].institutions[0].display_name | Inserm |
| authorships[1].institutions[1].id | https://openalex.org/I97188460 |
| authorships[1].institutions[1].ror | https://ror.org/03gnr7b55 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I97188460 |
| authorships[1].institutions[1].country_code | FR |
| authorships[1].institutions[1].display_name | Nantes Université |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Céline Bressollette-Bodin |
| authorships[1].is_corresponding | True |
| authorships[1].raw_affiliation_strings | Centre de Recherche en Transplantation et Immunologie (CRTI), UMR1064, INSERM, Université de Nantes, Nantes, France, Laboratoire de Virologie, CHU Nantes, Nantes, France |
| authorships[2].author.id | https://openalex.org/A5062186392 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-8818-1736 |
| authorships[2].author.display_name | Nathalie Gérard |
| authorships[2].countries | FR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210112643 |
| authorships[2].affiliations[0].raw_affiliation_string | Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I154526488, https://openalex.org/I97188460 |
| authorships[2].affiliations[1].raw_affiliation_string | Centre de Recherche en Transplantation et Immunologie (CRTI), UMR1064, INSERM, Université de Nantes, Nantes, France |
| authorships[2].institutions[0].id | https://openalex.org/I154526488 |
| authorships[2].institutions[0].ror | https://ror.org/02vjkv261 |
| authorships[2].institutions[0].type | government |
| authorships[2].institutions[0].lineage | https://openalex.org/I154526488 |
| authorships[2].institutions[0].country_code | FR |
| authorships[2].institutions[0].display_name | Inserm |
| authorships[2].institutions[1].id | https://openalex.org/I4210112643 |
| authorships[2].institutions[1].ror | https://ror.org/02dm0bq25 |
| authorships[2].institutions[1].type | facility |
| authorships[2].institutions[1].lineage | https://openalex.org/I154526488, https://openalex.org/I4210105774, https://openalex.org/I4210112643 |
| authorships[2].institutions[1].country_code | FR |
| authorships[2].institutions[1].display_name | Institut de Transplantation Urologie en Nephrologie |
| authorships[2].institutions[2].id | https://openalex.org/I97188460 |
| authorships[2].institutions[2].ror | https://ror.org/03gnr7b55 |
| authorships[2].institutions[2].type | education |
| authorships[2].institutions[2].lineage | https://openalex.org/I97188460 |
| authorships[2].institutions[2].country_code | FR |
| authorships[2].institutions[2].display_name | Nantes Université |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Nathalie Gérard |
| authorships[2].is_corresponding | True |
| authorships[2].raw_affiliation_strings | Centre de Recherche en Transplantation et Immunologie (CRTI), UMR1064, INSERM, Université de Nantes, Nantes, France, Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France |
| authorships[3].author.id | https://openalex.org/A5047490177 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-7641-1592 |
| authorships[3].author.display_name | Magali Giral |
| authorships[3].countries | FR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I97188460 |
| authorships[3].affiliations[0].raw_affiliation_string | Centre de Recherche en Transplantation et Immunologie (CRTI), UMR1064, INSERM, Université de Nantes, Nantes, France |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I4210112643 |
| authorships[3].affiliations[1].raw_affiliation_string | Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France |
| authorships[3].institutions[0].id | https://openalex.org/I154526488 |
| authorships[3].institutions[0].ror | https://ror.org/02vjkv261 |
| authorships[3].institutions[0].type | government |
| authorships[3].institutions[0].lineage | https://openalex.org/I154526488 |
| authorships[3].institutions[0].country_code | FR |
| authorships[3].institutions[0].display_name | Inserm |
| authorships[3].institutions[1].id | https://openalex.org/I4210112643 |
| authorships[3].institutions[1].ror | https://ror.org/02dm0bq25 |
| authorships[3].institutions[1].type | facility |
| authorships[3].institutions[1].lineage | https://openalex.org/I154526488, https://openalex.org/I4210105774, https://openalex.org/I4210112643 |
| authorships[3].institutions[1].country_code | FR |
| authorships[3].institutions[1].display_name | Institut de Transplantation Urologie en Nephrologie |
| authorships[3].institutions[2].id | https://openalex.org/I97188460 |
| authorships[3].institutions[2].ror | https://ror.org/03gnr7b55 |
| authorships[3].institutions[2].type | education |
| authorships[3].institutions[2].lineage | https://openalex.org/I97188460 |
| authorships[3].institutions[2].country_code | FR |
| authorships[3].institutions[2].display_name | Nantes Université |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Magali Giral |
| authorships[3].is_corresponding | True |
| authorships[3].raw_affiliation_strings | Centre de Recherche en Transplantation et Immunologie (CRTI), UMR1064, INSERM, Université de Nantes, Nantes, France, Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France |
| authorships[4].author.id | https://openalex.org/A5089422245 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-1766-0745 |
| authorships[4].author.display_name | Pierrick Guérif |
| authorships[4].countries | FR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210112643 |
| authorships[4].affiliations[0].raw_affiliation_string | Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France |
| authorships[4].institutions[0].id | https://openalex.org/I4210112643 |
| authorships[4].institutions[0].ror | https://ror.org/02dm0bq25 |
| authorships[4].institutions[0].type | facility |
| authorships[4].institutions[0].lineage | https://openalex.org/I154526488, https://openalex.org/I4210105774, https://openalex.org/I4210112643 |
| authorships[4].institutions[0].country_code | FR |
| authorships[4].institutions[0].display_name | Institut de Transplantation Urologie en Nephrologie |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Pierrick Guérif |
| authorships[4].is_corresponding | True |
| authorships[4].raw_affiliation_strings | Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France |
| authorships[5].author.id | https://openalex.org/A5112145344 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Audrey Rodallec |
| authorships[5].affiliations[0].raw_affiliation_string | Laboratoire de Virologie, CHU Nantes, Nantes, France |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Audrey Rodallec |
| authorships[5].is_corresponding | True |
| authorships[5].raw_affiliation_strings | Laboratoire de Virologie, CHU Nantes, Nantes, France |
| authorships[6].author.id | https://openalex.org/A5084574852 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-5012-6099 |
| authorships[6].author.display_name | Romain Oger |
| authorships[6].countries | FR |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I49451733, https://openalex.org/I97188460 |
| authorships[6].affiliations[0].raw_affiliation_string | CRCINA, UMR1232, INSERM, Université d'Angers, Université de Nantes, Nantes, France |
| authorships[6].institutions[0].id | https://openalex.org/I154526488 |
| authorships[6].institutions[0].ror | https://ror.org/02vjkv261 |
| authorships[6].institutions[0].type | government |
| authorships[6].institutions[0].lineage | https://openalex.org/I154526488 |
| authorships[6].institutions[0].country_code | FR |
| authorships[6].institutions[0].display_name | Inserm |
| authorships[6].institutions[1].id | https://openalex.org/I97188460 |
| authorships[6].institutions[1].ror | https://ror.org/03gnr7b55 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I97188460 |
| authorships[6].institutions[1].country_code | FR |
| authorships[6].institutions[1].display_name | Nantes Université |
| authorships[6].institutions[2].id | https://openalex.org/I49451733 |
| authorships[6].institutions[2].ror | https://ror.org/04yrqp957 |
| authorships[6].institutions[2].type | education |
| authorships[6].institutions[2].lineage | https://openalex.org/I49451733 |
| authorships[6].institutions[2].country_code | FR |
| authorships[6].institutions[2].display_name | Université d'Angers |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Romain Oger |
| authorships[6].is_corresponding | True |
| authorships[6].raw_affiliation_strings | CRCINA, UMR1232, INSERM, Université d'Angers, Université de Nantes, Nantes, France |
| authorships[7].author.id | https://openalex.org/A5016111785 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-9625-6825 |
| authorships[7].author.display_name | Tiphaine Parrot |
| authorships[7].countries | FR |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I49451733, https://openalex.org/I97188460 |
| authorships[7].affiliations[0].raw_affiliation_string | CRCINA, UMR1232, INSERM, Université d'Angers, Université de Nantes, Nantes, France |
| authorships[7].institutions[0].id | https://openalex.org/I154526488 |
| authorships[7].institutions[0].ror | https://ror.org/02vjkv261 |
| authorships[7].institutions[0].type | government |
| authorships[7].institutions[0].lineage | https://openalex.org/I154526488 |
| authorships[7].institutions[0].country_code | FR |
| authorships[7].institutions[0].display_name | Inserm |
| authorships[7].institutions[1].id | https://openalex.org/I97188460 |
| authorships[7].institutions[1].ror | https://ror.org/03gnr7b55 |
| authorships[7].institutions[1].type | education |
| authorships[7].institutions[1].lineage | https://openalex.org/I97188460 |
| authorships[7].institutions[1].country_code | FR |
| authorships[7].institutions[1].display_name | Nantes Université |
| authorships[7].institutions[2].id | https://openalex.org/I49451733 |
| authorships[7].institutions[2].ror | https://ror.org/04yrqp957 |
| authorships[7].institutions[2].type | education |
| authorships[7].institutions[2].lineage | https://openalex.org/I49451733 |
| authorships[7].institutions[2].country_code | FR |
| authorships[7].institutions[2].display_name | Université d'Angers |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Tiphaine Parrot |
| authorships[7].is_corresponding | True |
| authorships[7].raw_affiliation_strings | CRCINA, UMR1232, INSERM, Université d'Angers, Université de Nantes, Nantes, France |
| authorships[8].author.id | https://openalex.org/A5057446768 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-2217-1295 |
| authorships[8].author.display_name | Mathilde Allard |
| authorships[8].countries | FR |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I49451733, https://openalex.org/I97188460 |
| authorships[8].affiliations[0].raw_affiliation_string | CRCINA, UMR1232, INSERM, Université d'Angers, Université de Nantes, Nantes, France |
| authorships[8].institutions[0].id | https://openalex.org/I154526488 |
| authorships[8].institutions[0].ror | https://ror.org/02vjkv261 |
| authorships[8].institutions[0].type | government |
| authorships[8].institutions[0].lineage | https://openalex.org/I154526488 |
| authorships[8].institutions[0].country_code | FR |
| authorships[8].institutions[0].display_name | Inserm |
| authorships[8].institutions[1].id | https://openalex.org/I97188460 |
| authorships[8].institutions[1].ror | https://ror.org/03gnr7b55 |
| authorships[8].institutions[1].type | education |
| authorships[8].institutions[1].lineage | https://openalex.org/I97188460 |
| authorships[8].institutions[1].country_code | FR |
| authorships[8].institutions[1].display_name | Nantes Université |
| authorships[8].institutions[2].id | https://openalex.org/I49451733 |
| authorships[8].institutions[2].ror | https://ror.org/04yrqp957 |
| authorships[8].institutions[2].type | education |
| authorships[8].institutions[2].lineage | https://openalex.org/I49451733 |
| authorships[8].institutions[2].country_code | FR |
| authorships[8].institutions[2].display_name | Université d'Angers |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Mathilde Allard |
| authorships[8].is_corresponding | True |
| authorships[8].raw_affiliation_strings | CRCINA, UMR1232, INSERM, Université d'Angers, Université de Nantes, Nantes, France |
| authorships[9].author.id | https://openalex.org/A5062172662 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Anne Cesbron‐Gautier |
| authorships[9].countries | FR |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210128919 |
| authorships[9].affiliations[0].raw_affiliation_string | Etablissement Français du Sang (EFS), Région des Pays de la Loire, Nantes, France |
| authorships[9].institutions[0].id | https://openalex.org/I4210128919 |
| authorships[9].institutions[0].ror | https://ror.org/037hby126 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210128919 |
| authorships[9].institutions[0].country_code | FR |
| authorships[9].institutions[0].display_name | Établissement Français du Sang |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Anne Cesbron-Gautier |
| authorships[9].is_corresponding | True |
| authorships[9].raw_affiliation_strings | Etablissement Français du Sang (EFS), Région des Pays de la Loire, Nantes, France |
| authorships[10].author.id | https://openalex.org/A5031244376 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-0092-3919 |
| authorships[10].author.display_name | Nadine Gervois |
| authorships[10].countries | FR |
| authorships[10].affiliations[0].raw_affiliation_string | LabEx Immunology-Graft-Oncology (IGO), Nantes, France |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I154526488, https://openalex.org/I49451733, https://openalex.org/I97188460 |
| authorships[10].affiliations[1].raw_affiliation_string | CRCINA, UMR1232, INSERM, Université d'Angers, Université de Nantes, Nantes, France |
| authorships[10].institutions[0].id | https://openalex.org/I154526488 |
| authorships[10].institutions[0].ror | https://ror.org/02vjkv261 |
| authorships[10].institutions[0].type | government |
| authorships[10].institutions[0].lineage | https://openalex.org/I154526488 |
| authorships[10].institutions[0].country_code | FR |
| authorships[10].institutions[0].display_name | Inserm |
| authorships[10].institutions[1].id | https://openalex.org/I97188460 |
| authorships[10].institutions[1].ror | https://ror.org/03gnr7b55 |
| authorships[10].institutions[1].type | education |
| authorships[10].institutions[1].lineage | https://openalex.org/I97188460 |
| authorships[10].institutions[1].country_code | FR |
| authorships[10].institutions[1].display_name | Nantes Université |
| authorships[10].institutions[2].id | https://openalex.org/I49451733 |
| authorships[10].institutions[2].ror | https://ror.org/04yrqp957 |
| authorships[10].institutions[2].type | education |
| authorships[10].institutions[2].lineage | https://openalex.org/I49451733 |
| authorships[10].institutions[2].country_code | FR |
| authorships[10].institutions[2].display_name | Université d'Angers |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Nadine Gervois |
| authorships[10].is_corresponding | True |
| authorships[10].raw_affiliation_strings | CRCINA, UMR1232, INSERM, Université d'Angers, Université de Nantes, Nantes, France, LabEx Immunology-Graft-Oncology (IGO), Nantes, France |
| authorships[11].author.id | https://openalex.org/A5049578005 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-5870-4615 |
| authorships[11].author.display_name | Béatrice Charreau |
| authorships[11].countries | FR |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210112643 |
| authorships[11].affiliations[0].raw_affiliation_string | Institut Hospitalo-Universitaire European Center for Science in Transplantation and Immunology, Nantes, France |
| authorships[11].affiliations[1].raw_affiliation_string | LabEx Immunology-Graft-Oncology (IGO), Nantes, France |
| authorships[11].affiliations[2].institution_ids | https://openalex.org/I154526488, https://openalex.org/I97188460 |
| authorships[11].affiliations[2].raw_affiliation_string | Centre de Recherche en Transplantation et Immunologie (CRTI), UMR1064, INSERM, Université de Nantes, Nantes, France |
| authorships[11].affiliations[3].institution_ids | https://openalex.org/I4210112643 |
| authorships[11].affiliations[3].raw_affiliation_string | Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France |
| authorships[11].institutions[0].id | https://openalex.org/I154526488 |
| authorships[11].institutions[0].ror | https://ror.org/02vjkv261 |
| authorships[11].institutions[0].type | government |
| authorships[11].institutions[0].lineage | https://openalex.org/I154526488 |
| authorships[11].institutions[0].country_code | FR |
| authorships[11].institutions[0].display_name | Inserm |
| authorships[11].institutions[1].id | https://openalex.org/I4210112643 |
| authorships[11].institutions[1].ror | https://ror.org/02dm0bq25 |
| authorships[11].institutions[1].type | facility |
| authorships[11].institutions[1].lineage | https://openalex.org/I154526488, https://openalex.org/I4210105774, https://openalex.org/I4210112643 |
| authorships[11].institutions[1].country_code | FR |
| authorships[11].institutions[1].display_name | Institut de Transplantation Urologie en Nephrologie |
| authorships[11].institutions[2].id | https://openalex.org/I97188460 |
| authorships[11].institutions[2].ror | https://ror.org/03gnr7b55 |
| authorships[11].institutions[2].type | education |
| authorships[11].institutions[2].lineage | https://openalex.org/I97188460 |
| authorships[11].institutions[2].country_code | FR |
| authorships[11].institutions[2].display_name | Nantes Université |
| authorships[11].author_position | last |
| authorships[11].raw_author_name | Béatrice Charreau |
| authorships[11].is_corresponding | True |
| authorships[11].raw_affiliation_strings | Centre de Recherche en Transplantation et Immunologie (CRTI), UMR1064, INSERM, Université de Nantes, Nantes, France, Institut Hospitalo-Universitaire European Center for Science in Transplantation and Immunology, Nantes, France, Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France, LabEx Immunology-Graft-Oncology (IGO), Nantes, France |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1007041&type=printable |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10981 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2713 |
| primary_topic.subfield.display_name | Epidemiology |
| primary_topic.display_name | Cytomegalovirus and herpesvirus research |
| related_works | https://openalex.org/W1975816210, https://openalex.org/W3151653674, https://openalex.org/W2414729062, https://openalex.org/W1497833379, https://openalex.org/W1964266791, https://openalex.org/W4313313459, https://openalex.org/W3201134292, https://openalex.org/W1965096535, https://openalex.org/W2042042865, https://openalex.org/W2593076286 |
| cited_by_count | 37 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 4 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 6 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 8 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 6 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 3 |
| counts_by_year[6].year | 2019 |
| counts_by_year[6].cited_by_count | 6 |
| counts_by_year[7].year | 2018 |
| counts_by_year[7].cited_by_count | 3 |
| locations_count | 7 |
| best_oa_location.id | doi:10.1371/journal.ppat.1007041 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2004986 |
| best_oa_location.source.issn | 1553-7366, 1553-7374 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1553-7366 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | PLoS Pathogens |
| best_oa_location.source.host_organization | https://openalex.org/P4310315706 |
| best_oa_location.source.host_organization_name | Public Library of Science |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310315706 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1007041&type=printable |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | PLOS Pathogens |
| best_oa_location.landing_page_url | https://doi.org/10.1371/journal.ppat.1007041 |
| primary_location.id | doi:10.1371/journal.ppat.1007041 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2004986 |
| primary_location.source.issn | 1553-7366, 1553-7374 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1553-7366 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | PLoS Pathogens |
| primary_location.source.host_organization | https://openalex.org/P4310315706 |
| primary_location.source.host_organization_name | Public Library of Science |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315706 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1007041&type=printable |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | PLOS Pathogens |
| primary_location.landing_page_url | https://doi.org/10.1371/journal.ppat.1007041 |
| publication_date | 2018-04-30 |
| publication_year | 2018 |
| referenced_works | https://openalex.org/W2102864963, https://openalex.org/W1810287099, https://openalex.org/W2129477930, https://openalex.org/W2114635506, https://openalex.org/W2126658764, https://openalex.org/W1919257698, https://openalex.org/W2125334974, https://openalex.org/W1967790578, https://openalex.org/W2103849595, https://openalex.org/W2345588657, https://openalex.org/W2051103323, https://openalex.org/W2003803349, https://openalex.org/W1586815424, https://openalex.org/W2063060487, https://openalex.org/W2039635018, https://openalex.org/W2159305020, https://openalex.org/W1991524031, https://openalex.org/W2091352201, https://openalex.org/W1492184352, https://openalex.org/W2098918063, https://openalex.org/W2119485319, https://openalex.org/W2052667644, https://openalex.org/W2116171543, https://openalex.org/W1906987668, https://openalex.org/W2098379604, https://openalex.org/W2136558573, https://openalex.org/W2041413771, https://openalex.org/W1980662641, https://openalex.org/W1989166597, https://openalex.org/W2022711811, https://openalex.org/W1838943366, https://openalex.org/W2042750081, https://openalex.org/W2070214550, https://openalex.org/W2062840842, https://openalex.org/W2524753328, https://openalex.org/W2122745552, https://openalex.org/W1964653209, https://openalex.org/W2119345671, https://openalex.org/W2343060625, https://openalex.org/W2007851855, https://openalex.org/W1972282386, https://openalex.org/W1599436005, https://openalex.org/W2284841043, https://openalex.org/W2096119021, https://openalex.org/W2144099498, https://openalex.org/W2142014345, https://openalex.org/W2097855813, https://openalex.org/W2257411819, https://openalex.org/W1931478385, https://openalex.org/W1979273031, https://openalex.org/W2032625166, https://openalex.org/W2005670070, https://openalex.org/W2149000260, https://openalex.org/W1563277890, https://openalex.org/W2017004372, https://openalex.org/W1995138538, https://openalex.org/W140284416, https://openalex.org/W1986099961, https://openalex.org/W2166313015, https://openalex.org/W2082794963, https://openalex.org/W2171373682 |
| referenced_works_count | 61 |
| abstract_inverted_index.= | 100, 107 |
| abstract_inverted_index.T | 15, 27, 51, 132, 204, 245, 273 |
| abstract_inverted_index.a | 7, 63, 135, 171, 175, 218, 231, 250, 288 |
| abstract_inverted_index.(n | 99, 106 |
| abstract_inverted_index.11 | 138 |
| abstract_inverted_index.NK | 12 |
| abstract_inverted_index.as | 62 |
| abstract_inverted_index.at | 170, 286 |
| abstract_inverted_index.by | 35, 217 |
| abstract_inverted_index.ex | 122 |
| abstract_inverted_index.in | 69, 92, 116, 127, 151, 238, 256, 285 |
| abstract_inverted_index.of | 9, 77, 137, 146, 155, 165, 187, 201, 221, 253, 290 |
| abstract_inverted_index.to | 18, 23, 129, 153, 163, 293 |
| abstract_inverted_index.up | 152, 162 |
| abstract_inverted_index.we | 86, 110, 142 |
| abstract_inverted_index.1-3 | 257 |
| abstract_inverted_index.25) | 101 |
| abstract_inverted_index.32% | 154 |
| abstract_inverted_index.38% | 164 |
| abstract_inverted_index.CD8 | 14, 26, 50, 79, 131, 148, 168, 203, 211, 244, 272 |
| abstract_inverted_index.HLA | 36, 298 |
| abstract_inverted_index.The | 72 |
| abstract_inverted_index.Vβ | 234 |
| abstract_inverted_index.and | 13, 22, 42, 75, 88, 102, 109, 120, 185, 229, 268, 296 |
| abstract_inverted_index.are | 39, 195, 208, 247 |
| abstract_inverted_index.low | 219 |
| abstract_inverted_index.may | 160 |
| abstract_inverted_index.set | 8, 136, 252 |
| abstract_inverted_index.the | 112, 144, 188, 192, 199 |
| abstract_inverted_index.121) | 108 |
| abstract_inverted_index.HCMV | 30, 54, 239, 265 |
| abstract_inverted_index.IE1) | 33 |
| abstract_inverted_index.PD-1 | 222 |
| abstract_inverted_index.UL40 | 55, 189 |
| abstract_inverted_index.also | 67 |
| abstract_inverted_index.from | 95, 191 |
| abstract_inverted_index.have | 59 |
| abstract_inverted_index.host | 297 |
| abstract_inverted_index.most | 260 |
| abstract_inverted_index.some | 70 |
| abstract_inverted_index.take | 282 |
| abstract_inverted_index.that | 159, 281 |
| abstract_inverted_index.they | 43 |
| abstract_inverted_index.time | 172 |
| abstract_inverted_index.vivo | 123 |
| abstract_inverted_index.well | 40 |
| abstract_inverted_index.were | 125 |
| abstract_inverted_index.with | 45, 275 |
| abstract_inverted_index.HCMV+ | 157 |
| abstract_inverted_index.HLA-E | 182 |
| abstract_inverted_index.HLA-I | 261 |
| abstract_inverted_index.Here, | 85 |
| abstract_inverted_index.These | 206 |
| abstract_inverted_index.Thus, | 264 |
| abstract_inverted_index.Using | 134 |
| abstract_inverted_index.blood | 93, 97 |
| abstract_inverted_index.cells | 16, 21, 28, 52, 150, 207, 246, 274 |
| abstract_inverted_index.early | 227 |
| abstract_inverted_index.hosts | 158 |
| abstract_inverted_index.human | 3 |
| abstract_inverted_index.least | 287 |
| abstract_inverted_index.level | 220 |
| abstract_inverted_index.major | 196 |
| abstract_inverted_index.place | 283 |
| abstract_inverted_index.point | 173 |
| abstract_inverted_index.their | 117 |
| abstract_inverted_index.these | 90 |
| abstract_inverted_index.third | 289 |
| abstract_inverted_index.total | 166 |
| abstract_inverted_index.virus | 47, 294 |
| abstract_inverted_index.αβT | 149 |
| abstract_inverted_index.(HCMV) | 5 |
| abstract_inverted_index.(pp65, | 32 |
| abstract_inverted_index.CCR7-, | 213 |
| abstract_inverted_index.CD27-, | 214 |
| abstract_inverted_index.CD28-) | 215 |
| abstract_inverted_index.Host's | 179 |
| abstract_inverted_index.Immune | 0 |
| abstract_inverted_index.T-cell | 65, 80 |
| abstract_inverted_index.appear | 226 |
| abstract_inverted_index.broad, | 232 |
| abstract_inverted_index.cells. | 133, 205 |
| abstract_inverted_index.donors | 98 |
| abstract_inverted_index.hosts. | 71 |
| abstract_inverted_index.kidney | 103 |
| abstract_inverted_index.memory | 210 |
| abstract_inverted_index.mostly | 83 |
| abstract_inverted_index.or/and | 278 |
| abstract_inverted_index.remain | 82 |
| abstract_inverted_index.signal | 56, 262 |
| abstract_inverted_index.strain | 194, 295 |
| abstract_inverted_index.strong | 176, 267 |
| abstract_inverted_index.toward | 249 |
| abstract_inverted_index.T-cells | 169 |
| abstract_inverted_index.against | 2, 29 |
| abstract_inverted_index.allele, | 181 |
| abstract_inverted_index.broader | 251 |
| abstract_inverted_index.class-I | 37 |
| abstract_inverted_index.devoted | 17 |
| abstract_inverted_index.display | 230 |
| abstract_inverted_index.emerged | 61 |
| abstract_inverted_index.factors | 197 |
| abstract_inverted_index.healthy | 96 |
| abstract_inverted_index.induced | 237 |
| abstract_inverted_index.induces | 266 |
| abstract_inverted_index.lasting | 270 |
| abstract_inverted_index.manner, | 242 |
| abstract_inverted_index.peptide | 140, 190 |
| abstract_inverted_index.prevent | 24 |
| abstract_inverted_index.samples | 94 |
| abstract_inverted_index.varying | 255 |
| abstract_inverted_index.Although | 236 |
| abstract_inverted_index.HLA-A*02 | 180 |
| abstract_inverted_index.analyses | 124 |
| abstract_inverted_index.antigens | 31 |
| abstract_inverted_index.control. | 48 |
| abstract_inverted_index.detected | 87 |
| abstract_inverted_index.effector | 209 |
| abstract_inverted_index.features | 76 |
| abstract_inverted_index.genotype | 184 |
| abstract_inverted_index.includes | 6 |
| abstract_inverted_index.infected | 20 |
| abstract_inverted_index.involved | 115 |
| abstract_inverted_index.observed | 68 |
| abstract_inverted_index.peptides | 57 |
| abstract_inverted_index.presence | 145 |
| abstract_inverted_index.reactive | 248 |
| abstract_inverted_index.recently | 60 |
| abstract_inverted_index.residues | 258 |
| abstract_inverted_index.response | 1, 66 |
| abstract_inverted_index.sequence | 186 |
| abstract_inverted_index.unknown. | 84 |
| abstract_inverted_index.HLA-EUL40 | 78, 147, 202, 224, 243, 271 |
| abstract_inverted_index.according | 292 |
| abstract_inverted_index.affecting | 198 |
| abstract_inverted_index.associate | 44 |
| abstract_inverted_index.cytotoxic | 11 |
| abstract_inverted_index.efficient | 46 |
| abstract_inverted_index.eliminate | 19 |
| abstract_inverted_index.expansion | 177 |
| abstract_inverted_index.incidence | 200 |
| abstract_inverted_index.including | 259 |
| abstract_inverted_index.infecting | 193 |
| abstract_inverted_index.life-long | 269 |
| abstract_inverted_index.molecules | 38 |
| abstract_inverted_index.peptides. | 263 |
| abstract_inverted_index.performed | 126 |
| abstract_inverted_index.phenotype | 121 |
| abstract_inverted_index.potential | 276 |
| abstract_inverted_index.presented | 34 |
| abstract_inverted_index.represent | 161 |
| abstract_inverted_index.responses | 81, 91, 225 |
| abstract_inverted_index.targeting | 53 |
| abstract_inverted_index.tetramers | 141 |
| abstract_inverted_index.unbiased, | 233 |
| abstract_inverted_index.HLA-E/UL40 | 139 |
| abstract_inverted_index.allogeneic | 277 |
| abstract_inverted_index.autologous | 279 |
| abstract_inverted_index.biological | 113 |
| abstract_inverted_index.comparison | 128 |
| abstract_inverted_index.infections | 291 |
| abstract_inverted_index.persistent | 10 |
| abstract_inverted_index.quantified | 89 |
| abstract_inverted_index.reactivity | 280 |
| abstract_inverted_index.recipients | 105 |
| abstract_inverted_index.suggesting | 174 |
| abstract_inverted_index.transplant | 104 |
| abstract_inverted_index.(HLA-EUL40) | 58 |
| abstract_inverted_index.circulating | 167 |
| abstract_inverted_index.expression. | 223 |
| abstract_inverted_index.occurrence, | 73 |
| abstract_inverted_index.occurrence. | 118 |
| abstract_inverted_index.repertoire. | 235 |
| abstract_inverted_index.selectively | 284 |
| abstract_inverted_index.specificity | 74 |
| abstract_inverted_index.Longitudinal | 119 |
| abstract_inverted_index.concordance. | 299 |
| abstract_inverted_index.demonstrated | 143 |
| abstract_inverted_index.determinants | 114 |
| abstract_inverted_index.investigated | 111 |
| abstract_inverted_index.nonapeptides | 254 |
| abstract_inverted_index.seropositive | 156 |
| abstract_inverted_index.*01:01/*01:03 | 183 |
| abstract_inverted_index.characterized | 41, 216 |
| abstract_inverted_index.reactivation. | 25 |
| abstract_inverted_index.post-infection | 228 |
| abstract_inverted_index.cytomegalovirus | 4 |
| abstract_inverted_index.post-infection. | 178 |
| abstract_inverted_index.HLA-E-restricted | 49 |
| abstract_inverted_index.non-conventional | 64 |
| abstract_inverted_index.(CD45RAhighROlow, | 212 |
| abstract_inverted_index.strain-dependent, | 240 |
| abstract_inverted_index.UL4015-23-specific | 241 |
| abstract_inverted_index.HLA-A*02/pp65-specific | 130 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 91 |
| corresponding_author_ids | https://openalex.org/A5062186392, https://openalex.org/A5062172662, https://openalex.org/A5089422245, https://openalex.org/A5047490177, https://openalex.org/A5046171847, https://openalex.org/A5084574852, https://openalex.org/A5057446768, https://openalex.org/A5031244376, https://openalex.org/A5112145344, https://openalex.org/A5016111785, https://openalex.org/A5082674992, https://openalex.org/A5049578005 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 12 |
| corresponding_institution_ids | https://openalex.org/I154526488, https://openalex.org/I4210112643, https://openalex.org/I4210128919, https://openalex.org/I49451733, https://openalex.org/I97188460 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7699999809265137 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.91180831 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |